Vimentin was highly expressed at protein level in AML cells in vitro (Fig. 6b) and loss-of-function editing of vimentin resulted in a modest competitive growth advantage of AML cells under imetelstat pressure (Fig. 6c). This evidence concerns the gene VIM and acute myeloid leukemia.